Please join us for a session that will focus on how evolving data mining capabilities and advanced technologies, such as artificial intelligence and genomics, will impact clinical trials and healthcare innovation. This high-profile event highlights opportunities for the industry to innovate clinical trials through these technologies and to promote Ontario and Quebec’s joint capabilities for conducting clinical trials.

Dr. Molly Shoichet PhD, O.C., O. Ont., NAE
Ontario’s first Chief Scientist and a world-leading expert in the study of polymers for drug delivery and in tissue regeneration, with a focus on spinal cord injuries, strokes and blindness.

Rémi Quirion, OC, PhD, CQ, FRSC
Québec’s first Chief Scientist and chair on the boards of directors for the three Fonds de recherche du Québec and
advises the Minister of Economy, Science and Innovation on research and scientific development issues.

Michael Duong, PhD
Director for Evidence Generation in Medical Affairs for Hoffmann-La Roche Limited, managing a team responsible for medical research in Canada, including clinical trials, real-world data sciences, health outcomes research, and biostatistics.

Additional panelists to be confirmed.


Nous vous suggérons